Healthcare Sector

Panometrix Corporation’s strategic investments in the health sector, particularly with a significant focus in Singapore, underscore our commitment to advancing healthcare innovation, improving access to care, and promoting sustainable health solutions across the globe. Our involvement in Singapore’s thriving health sector is part of our broader strategy to support leading-edge projects and companies in medical technology, patient care, and health infrastructure around the world, recognizing the pivotal role of health and well-being in global development.

INVESTMENT FOCUS AREAS

Medical Technology and Innovation

Our investments span from Singapore to other key markets such as the United States, Germany, and Japan, focusing on revolutionary medical technologies and digital health solutions. From telemedicine to wearable devices and AI-driven diagnostics, we aim to transform healthcare delivery worldwide.

Healthcare Infrastructure

Beyond Singapore, we finance the development and modernization of hospitals, clinics, and health centers in countries like India, Brazil, and South Africa. These projects prioritize sustainable design and technology to create facilities that are resilient, eco-friendly, and responsive to community needs.

Pharmaceuticals and Research

We support pharmaceutical companies and research institutions across the globe, including in the UK, Canada, and Australia, working on groundbreaking treatments and vaccines. Our investments are aimed at addressing global health challenges, with a focus on innovation that ensures affordability and access.

Public Health Initiative

Panometrix champions public health initiatives aimed at improving health outcomes on a wide scale, from preventive care programs in the United Arab Emirates to health education in Kenya and access to clean water and sanitation in Indonesia, underscoring the interconnectedness of these factors in achieving overall health and well-being.

Global Reach and Impact

Our investments in the health sector reflect a comprehensive global vision, engaging in strategic projects and partnerships in both developed and emerging markets:

Innovative Healthcare Solutions:

ith over £1 billion allocated towards the development and deployment of medical technologies and digital health platforms, we’ve impacted millions of patients by enhancing access to care and the quality of diagnostics and treatment services, not just in Singapore but also in regions like North America, Europe, and Asia-Pacific.

Infrastructure Development

An investment exceeding £2 billion has facilitated the establishment and upgrade of healthcare facilities, directly improving healthcare access and environments for over 20 million people worldwide, including significant contributions in countries like India, Brazil, and South Africa.

Research and Pharmaceuticals

Our support of £800 million in the pharmaceutical sector has catalyzed the development of essential medications and vaccines, benefiting populations globally and addressing pressing health challenges, with notable advancements in the UK, Canada, and Australia.

Commitment to Sustainability and Equity

Our approach to health sector investments, guided by principles of sustainability and equity, prioritizes projects that promise not only financial returns but also positive contributions to environmental sustainability and equitable access to healthcare services. Whether it’s in Singapore, the United States, Germany, Japan, or emerging markets like India and Brazil, our goal is to foster a health ecosystem that is resilient, innovative, and capable of meeting the needs of diverse populations worldwide.